Related Experiment Video
Updated: Jun 17, 2026

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
Published on: November 8, 2018
Electroencephalographic changes in pyridoxine-dependant epilepsy: new observations
Georges Naasan1, Mohamad Yabroudi, Amal Rahi
1Department of Pediatrics, American University of Beirut, Medical Center, Beirut, Lebanon.
Pyridoxine-dependent epilepsy (PDE) EEG findings can fluctuate after treatment. Abnormal EEG patterns may persist for up to 43 months, even with pyridoxine, highlighting the need for careful monitoring.
Area of Science:
- Neurology
- Epilepsy Research
- Clinical Neurophysiology
Background:
- Pyridoxine-dependent epilepsy (PDE) is a rare genetic disorder.
- EEG manifestations in PDE are not fully characterized.
- Understanding EEG patterns is crucial for diagnosis and management.
Purpose of the Study:
- To describe EEG findings in four patients with pyridoxine-dependent epilepsy.
- To characterize the evolution of EEG patterns before, during, and after pyridoxine treatment.
- To identify novel EEG characteristics associated with PDE.
Main Methods:
- Retrospective review of EEG tracings from four PDE patients.
- Analysis of EEG recordings before, immediately after, and during long-term pyridoxine treatment.
- Correlation of EEG findings with clinical seizure activity and treatment response.
Main Results:
- Pre-treatment EEGs showed diffuse slowing, multifocal epileptiform discharges, and burst suppression patterns.
- Post-treatment, one patient showed immediate seizure cessation but persistent burst suppression for days.
- EEG abnormalities, including slowing and intermittent sharp waves, could persist for up to 43 months.
Conclusions:
- Burst suppression patterns can persist for up to five days post-pyridoxine initiation and do not rule out PDE.
- Transient worsening of EEG discharges may occur for up to three weeks after starting pyridoxine.
- Abnormal EEGs in PDE can normalize over months or improve with pyridoxine dose adjustments.
More Related Videos
11:54Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy
Published on: January 29, 2018
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...